National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

valproic acid
A synthetic derivative of propylpentanoic acid with antiepileptic properties and potential antineoplastic and antiangiogenesis activities. In epilepsy, valproic acid appears to act by increasing the concentration of gamma-aminobutyric acid (GABA) in the brain. This agent's antitumor and antiangiogenesis activities may be related to the inhibition of histone deacetylases and nitric oxide synthase, which results in the inhibition of nitric oxide synthesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Valproate
Valproate Sodium
US brand name:Depakene
Foreign brand names:Alti-Valproic
Ergenyl
Novo-Valproic
Abbreviation:VA
Chemical structure names:
  • 2-Propylpentanoic Acid
  • 2-Propylvaleric Acid
  • Di-n-propylacetic Acid



Previous:valacyclovir, Valcyte, valdecoxib, Valeriana officinalis extract, valganciclovir
Next:valrubicin, valsartan, valspodar, Valstar, Valtrex

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov